Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Rodman David Malcom
Chief Medical Officer at Mineralys Therapeutics. Filing since 10 Aug 2023.
CIK 0001672659
Company
Date
Role
Action
Shares
Amount
Of holding
MLYS
Mineralys Therapeutics, Inc.
10 Aug 2026
Chief Medical Officer
Sold on a plan
2,170
$58.79K
4.1%
MLYS
Mineralys Therapeutics, Inc.
17 Jul 2026
Chief Medical Officer
Sold on a plan
416
$11.04K
0.8%
MLYS
Mineralys Therapeutics, Inc.
15 Jul 2026
Chief Medical Officer
Sold on a plan
6,349
$168.95K
11.0%
MLYS
Mineralys Therapeutics, Inc.
13 Jul 2026
Chief Medical Officer
Sold on a plan
14,058
$387.72K
19.6%
MLYS
Mineralys Therapeutics, Inc.
9 Jul 2026
Chief Medical Officer
Sold on a plan
2,171
$65.78K
3.6%
MLYS
Mineralys Therapeutics, Inc.
17 Jun 2026
Chief Medical Officer
Sold on a plan
4,584
$114.60K
7.4%
MLYS
Mineralys Therapeutics, Inc.
15 Jun 2026
Chief Medical Officer
Sold on a plan
9,890
$235.49K
14.8%
MLYS
Mineralys Therapeutics, Inc.
12 Jun 2026
Chief Medical Officer
Sold on a plan
6,349
$151.90K
9.1%
MLYS
Mineralys Therapeutics, Inc.
10 Jun 2026
Chief Medical Officer
Sold on a plan
2,170
$54.25K
3.3%
MLYS
Mineralys Therapeutics, Inc.
18 May 2026
Chief Medical Officer
Sold on a plan
417
$11.49K
0.7%
MLYS
Mineralys Therapeutics, Inc.
13 May 2026
Chief Medical Officer
Sold on a plan
14,056
$401.79K
18.1%
MLYS
Mineralys Therapeutics, Inc.
12 May 2026
Chief Medical Officer
Sold on a plan
6,348
$186.35K
8.3%
MLYS
Mineralys Therapeutics, Inc.
11 May 2026
Chief Medical Officer
Sold on a plan
2,171
$64.50K
3.0%
MLYS
Mineralys Therapeutics, Inc.
17 Apr 2026
Chief Medical Officer
Sold on a plan
416
$13.03K
0.6%
MLYS
Mineralys Therapeutics, Inc.
15 Apr 2026
Chief Medical Officer
Sold on a plan
6,348
$175.59K
8.3%
MLYS
Mineralys Therapeutics, Inc.
13 Apr 2026
Chief Medical Officer
Sold on a plan
14,058
$373.09K
15.6%
MLYS
Mineralys Therapeutics, Inc.
9 Apr 2026
Chief Medical Officer
Sold on a plan
2,170
$59.41K
2.8%
MLYS
Mineralys Therapeutics, Inc.
17 Mar 2026
Chief Medical Officer
Sold on a plan
417
$10.70K
0.5%
MLYS
Mineralys Therapeutics, Inc.
13 Mar 2026
Chief Medical Officer
Sold on a plan
14,058
$369.23K
15.6%
MLYS
Mineralys Therapeutics, Inc.
12 Mar 2026
Chief Medical Officer
Sold on a plan
6,348
$173.75K
7.1%
MLYS
Mineralys Therapeutics, Inc.
9 Mar 2026
Chief Medical Officer
Sold on a plan
2,171
$58.27K
2.6%
MLYS
Mineralys Therapeutics, Inc.
17 Feb 2026
Chief Medical Officer
Sold on a plan
417
$11.51K
0.9%
MLYS
Mineralys Therapeutics, Inc.
13 Feb 2026
Chief Medical Officer
Sold on a plan
14,055
$385.73K
24.2%
MLYS
Mineralys Therapeutics, Inc.
12 Feb 2026
Chief Medical Officer
Sold on a plan
6,349
$184.08K
11.2%
MLYS
Mineralys Therapeutics, Inc.
9 Feb 2026
Chief Medical Officer
Sold on a plan
2,171
$65.59K
4.1%
MLYS
Mineralys Therapeutics, Inc.
20 Jan 2026
Chief Medical Officer
Sold on a plan
416
$13.35K
0.8%
MLYS
Mineralys Therapeutics, Inc.
14 Jan 2026
Chief Medical Officer
Sold on a plan
11,367
$370.64K
18.4%
MLYS
Mineralys Therapeutics, Inc.
13 Jan 2026
Chief Medical Officer
Sold on a plan
7,709
$252.47K
11.1%
MLYS
Mineralys Therapeutics, Inc.
12 Jan 2026
Chief Medical Officer
Sold on a plan
6,348
$205.14K
9.3%
MLYS
Mineralys Therapeutics, Inc.
9 Jan 2026
Chief Medical Officer
Sold on a plan
2,170
$72.20K
3.4%
MLYS
Mineralys Therapeutics, Inc.
5 Jan 2026
Chief Medical Officer
Sold on a plan
192,715
$6.75M
75.7%
MLYS
Mineralys Therapeutics, Inc.
2 Jan 2026
Chief Medical Officer
Sold on a plan
70,037
$2.51M
50.3%
MLYS
Mineralys Therapeutics, Inc.
15 Oct 2025
Chief Medical Officer
Sold on a plan
10,369
$445.98K
12.7%
MLYS
Mineralys Therapeutics, Inc.
15 Sep 2025
Chief Medical Officer
Sold on a plan
11,367
$409.27K
12.2%
MLYS
Mineralys Therapeutics, Inc.
13 Aug 2025
Chief Medical Officer
Sold on a plan
11,365
$146.99K
10.9%
MLYS
Mineralys Therapeutics, Inc.
14 Jul 2025
Chief Medical Officer
Sold on a plan
11,366
$165.88K
10.4%
MLYS
Mineralys Therapeutics, Inc.
13 Jun 2025
Chief Medical Officer
Sold on a plan
11,366
$165.93K
10.1%
MLYS
Mineralys Therapeutics, Inc.
14 May 2025
Chief Medical Officer
Sold on a plan
11,366
$173.77K
9.6%
MLYS
Mineralys Therapeutics, Inc.
14 Apr 2025
Chief Medical Officer
Sold on a plan
11,366
$165.19K
9.2%
MLYS
Mineralys Therapeutics, Inc.
1 Apr 2025
Chief Medical Officer
Sold on a plan
55,771
$879.01K
32.3%
MLYS
Mineralys Therapeutics, Inc.
11 Nov 2024
Chief Medical Officer
Sold on a plan
5,026
$75.40K
3.4%
MLYS
Mineralys Therapeutics, Inc.
6 Nov 2024
Chief Medical Officer
Sold on a plan
25,482
$383.07K
15.8%
MLYS
Mineralys Therapeutics, Inc.
16 Jul 2024
Chief Medical Officer
Sold on a plan
525
$7.88K
0.5%
MLYS
Mineralys Therapeutics, Inc.
9 May 2024
Chief Medical Officer
Sold on a plan
100
$1.50K
0.1%
MLYS
Mineralys Therapeutics, Inc.
11 Aug 2023
Chief Medical Officer
Sold at will
157,091
$2.01M
100%
MLYS
Mineralys Therapeutics, Inc.
10 Aug 2023
Chief Medical Officer
Sold at will
74,625
$982.07K
100%
46 decisions on file.
